Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Deficiency, Antibody”

335 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 335 results

Early research (Phase 1)Study completedNCT01403792
What this trial is testing

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Who this might be right for
Human Immunodeficiency Virus
University of Surrey 11
Early research (Phase 1)Study completedNCT03205917
What this trial is testing

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 29
Not applicableNot Yet RecruitingNCT07516002
What this trial is testing

Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases
Peking University People's Hospital 15
Large-scale testing (Phase 3)Study completedNCT00751621
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

Who this might be right for
Primary Immunodeficiency (PID)
CSL Behring 40
Large-scale testing (Phase 3)UnknownNCT03578341
What this trial is testing

Oral Colostrum and Its Effect on Immune System

Who this might be right for
Immune System DiseasesPremature Infant DiseaseImmunoglobulin Deficiency
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 96
Not applicableStudy completedNCT01859754
What this trial is testing

Octagam 5% Versus Comparator Post Marketing Trial

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 623
Early research (Phase 1)Study completedNCT00069030
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT05028881
What this trial is testing

COVID-19 Serology in People Living with HIV in Hong Kong

Who this might be right for
HIV InfectionsSARS-CoV-2 InfectionVaccination; Infection
Chinese University of Hong Kong 488
Testing effectiveness (Phase 2)Ended earlyNCT02963064
What this trial is testing

JSP191 Antibody Targeting Conditioning in SCID Patients

Who this might be right for
SCID
Jasper Therapeutics, Inc. 23
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Not applicableUnknownNCT03334552
What this trial is testing

Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.

Who this might be right for
HIV/AIDS
Michael Hoelscher 500
Large-scale testing (Phase 3)Study completedNCT04561115
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Who this might be right for
Primary Immunodeficiency
Grifols Therapeutics LLC 33
Early research (Phase 1)Study completedNCT00000884
What this trial is testing

Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Not applicableEnded earlyNCT02960399
What this trial is testing

Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

Who this might be right for
Common Variable Immune DeficiencySpecific Antibody DeficiencyX-linked Agammaglobulinemia
University of South Florida 2
Not applicableStudy completedNCT05689515
What this trial is testing

Feasibility of Positive Links for Youth Care Engagement Intervention

Who this might be right for
HIV Antibody Positivity
The University of Texas Health Science Center at San Antonio 29
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Testing effectiveness (Phase 2)Study completedNCT00115778
What this trial is testing

Intravenous Immunoglobulin (IVIG) in Lung Transplantation

Who this might be right for
HypogammaglobulinemiaLung Transplantation
Columbia University 11
Early research (Phase 1)Study completedNCT00000721
What this trial is testing

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)Looking for participantsNCT04319367
What this trial is testing

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Who this might be right for
HIV/AIDS and Infections
Imperial College London 72
Large-scale testing (Phase 3)Study completedNCT00538915
What this trial is testing

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Who this might be right for
Primary Immune Deficiency Disorders (PIDD)
ADMA Biologics, Inc. 63
Next Page